Sexual Habits Affect Penis Size in Adulthood

NCT ID: NCT05654974

Last Updated: 2024-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

282 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-01

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: to assess in Kazakh adult males erect penis sizes, and study an influence of their natural physiological events and behavioral habits during their growing ages on their penile sizes nowadays.

Study Design: An observational cross-sectional survey pilot study using a correlational design with the intention-to-treat principle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants. A total of 282 adult Kazakh males from the Republic of Kazakhstan and who have been visited at the urology units of three university centers in the biggest cities of the Republic of Kazakhstan (Astana, Almaty, and Karaganda) were prospectively included in the study, which took place between January 2020 and January 2021.

Measurements of the penis erect length and girth were by two doctor-urologists according to the method of Veale D et al. (2015).

Statistical analysis. Two-tailed Student's t-test, Pearson correlation and multivariate tests of the MANOVA and MANCOVA (body height as covariate) were used.

Sample size estimation. In a cross-sectional observational study in assessment of erect penis size of Kazakh adult males we supposed that the primary interest lies in assessment of erect penis sizes in the three cities (k=3). The investigators wish to be 95% sure of detecting when the mean erect penis sizes not exceed 1 mm (i.e., 1-β=0.95, and m1=1, m2=0). The standard deviation of erect penis size is likely to be 1.56 mm (i.e. SD=1.56) with a statistical power of 95% and significance level of 2.5% with the Bonferroni correction based on one-sided hypothesis testing. At the 5% Type I error rate (i.e., α=0.05), the sample size of the survey is 196.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Observational Study

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

measurements and questionnaire

paper-based survey administration; erect penis length and girth measurements

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male gender aged from 23 to 35 years
* fill out the questionnaire
* BMI ≤ 29.9 kilogram per meter square
* a male who has at least one healthy native child
* no non-communicable chronic diseases.

Exclusion Criteria

* female gender
* BMI ≥ 30.0 kilogram per meter square
* infertility
* erectile dysfunction, previous pelvic surgery, suspected hypogonadism, penile disease, or deformity
* specific treatment with androgens
* alcohol or drug abuse
* history of alcohol consumption ≥ 30 g/day within the past 5 years.
Minimum Eligible Age

23 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center, Kazakhstan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kuat Oshakbayev

a principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bibazhar Dukenbayeva, Dr.

Role: STUDY_DIRECTOR

ANADETO medical center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kuat Pernekulovich Oshakbayev

Astana, , Kazakhstan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Kazakhstan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0000187

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Penile Injection Anxiety
NCT00582231 ACTIVE_NOT_RECRUITING
L-Arginine and Erectile Dysfunction
NCT00777075 COMPLETED PHASE4